JANX · Janux Therapeutics, Inc. · Share Buybacks
$16.90
-0.30 (-1.74%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$1.05B
Shares
61.14M
Volume · Oct 21
587.34K
Avg daily vol (3M)
844.04K
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-05 | — | $150,000,000 | $150,000,000 as of 2026-06-30 | — | 10-Q , filed 2026-08-06 |
Key facts
CIK
1817713
CUSIP
47103J105
13F (30d)
15 filings
15 filers
Visit website
Investor relations